Nuclear medicine slump hits Sopha
The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the
The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the last three quarters.
The nuclear medicine market nosedived in the fourth quarterof 1993, and by most accounts has yet to return to its formerstrength (SCAN 4/6/94). Gamma camera vendors have been scramblingto adapt, including Sopha competitor ADAC Laboratories, whichimplemented a similar downsizing earlier this year (SCAN 5/4/94).
Most of the lost jobs at Sopha will come from production andadministrative support personnel, the Columbia, MD-based companysaid. Sopha has taken pains to avoid impacting customer serviceor R&D, according to president Colin McNaught.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
